The global Animal Drug Compounding Market size was valued at USD 1.7 billion in 2025 and is projected to grow from USD 1.8 billion in 2026 to USD 3.3 billion by 2033, registering a CAGR of 8.5% from 2026 to 2033. North America accounted for the largest revenue share of 37.2% in 2025, driven by advanced veterinary healthcare infrastructure, high pet ownership rates, and increasing...

The global animal ultrasound market size was estimated at USD 539.39 million in 2025 and is projected to reach USD 998.76 million by 2033, growing at a CAGR of 8.19% from 2026 to 2033. The market is witnessing strong growth due to increasing veterinary healthcare expenditure, expanding applications of ultrasound technologies in animal diagnostics, rising pet insurance adoption, and...

The global Fluoroscopy Systems Market size was valued at USD 2.2 billion in 2025 and is projected to grow from USD 2.3 billion in 2026 to USD 2.9 billion by 2033, at a CAGR of 3.4% from 2026 to 2033. North America dominated the market with the largest revenue share of 42.1% in 2025. Market growth is primarily driven by the rising geriatric population, increasing prevalence of chronic...

The global Therapy Devices Market mental health treatment solutions. As healthcare systems increasingly prioritize non-invasive and long-term therapeutic approaches, therapy devices are becoming integral to modern patient care across hospitals, rehabilitation centers, and home healthcare environments. Therapy Devices Market Overview The therapy devices industry is experiencing...

The first quarter of 2026 has inaugurated a pivotal shift toward autonomous documentation protocols to mitigate the severe global nursing deficit. New directives from the Global Health Alliance have accelerated the deployment of ambient voice technology within high-acuity wards, effectively removing physical keyboards from the bedside environment. This transition is exceptionally visible in...

As 2026 begins, hospitals across North America and Europe are implementing a new set of digital safeguards designed to eliminate human error during perioperative care. The recent update to the Global Anesthesia Safety Framework has catalyzed a shift toward closed-loop systems that monitor patient vitals and adjust agent delivery in real-time. This movement is particularly visible in high-volume...

The full FDA approval of trastuzumab deruxtecan for HER2-mutant NSCLC in January 2026 marks the arrival of antibody-drug conjugates as a mainstream lung cancer treatment class, triggering a competitive ADC development wave across HER2, HER3, TROP2, and MET targets that is fundamentally reshaping the thoracic oncology commercial landscape. DESTINY-Lung02 trial data demonstrating a 49.0%...

As 2026 commences, global health authorities are enforcing a transition from siloed electronic records to a unified longitudinal patient view. This evolution is driven by the recent World Health Assembly resolution aimed at eliminating data fragmentation that currently hinders emergency response and chronic care management. With the integration of advanced semantic layers, clinicians in major...

The pharmaceutical industry is increasingly focused on addressing prescription drug misuse and opioid abuse through innovative drug formulation technologies. Abuse deterrent formulation (ADF) technologies have emerged as a critical solution for reducing the potential misuse, abuse, and diversion of prescription medications while ensuring effective pain management for patients. These...

The China Adenomyosis Market, GCC Adenomyosis Market, and Germany Adenomyosis Market are witnessing significant growth due to increasing awareness of women’s reproductive health and improvements in diagnostic technologies. Adenomyosis, a condition characterized by the presence of endometrial tissue within the uterine muscles, is becoming more widely diagnosed due to advancements in...